Schrodinger Inc. Stock News

NEW YORK--( BUSINESS WIRE )--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will participate in the Jefferies 13th Annual London Healthcare Conference in London, UK.

During the current earnings season, a few of the companies whose stocks I own delivered great third-quarter results. These results, along with their other achievements, shows that the firms' technolog

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 8.20% and 14.37%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that new pre

NEW YORK--(BUSINESS WIRE)---- $SDGR--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third qu

When compiling my small-cap stock picks, I tried to choose names that seemed to be benefiting from this new, more “risk-on” environment. Among the encouraging features of the August Consumer Price

Schrödinger reported mixed Q2 earnings with a miss on EPS and a beat on revenue. The company experienced strong performance across both aspects of the company business. The company revealed another q

Schrodinger, Inc. (NASDAQ:SDGR ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Jaren Madden - SVP, IR & Corporate Communications Ramy Farid - CEO, President & Directo

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of -1.64% and 2.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at the Jefferies Healthcare Conference.

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Citi Biotech Virtual Co-Panel Day.

Schrödinger, Inc. (NASDAQ:SDGR ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Jaren Madden – Senior Vice President of Investor Relations and Corporate Affairs Ramy F

These hypergrowth stocks are bargains after retreating for much of the last year. They will all perform very well for long-term investors.

Schrödinger software platform makes it chiefly a healthcare technology company; however, the company is developing an impressive pipeline and list partners from their drug discovery efforts.